Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-067638
Filing Date
2012-12-12
Accepted
2012-12-12 16:30:56
Documents
1
Period of Report
2012-12-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v330220_4.html 4  
1 OWNERSHIP DOCUMENT v330220_4.xml 4 3584
  Complete submission text file 0001144204-12-067638.txt   5214
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2109 BROADWAY, SUITE 206 NEW YORK NY 10023
Business Address
Herskowitz Neil (Reporting) CIK: 0001298246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 121259486